Choose language
Do you want to set the chosen language as default?
Yes, set as default
Search
Trending Topics
Index

Nasdaq

 Commodities

Oil prices

 Stock

Intel

 Stock

SpaceX

 Stock

Nvidia

 Crypto

Bitcoin

Stocks

View all

ETFs

View all

Cryptocurrencies

View all

Tools

VXRT

Vaxart Inc.

Price

$0.49

return (12m)

25.97% Logo

p/e

3.04

p/bv

1.42

DIVIDEND YIELD

0.00%
Price

VXRT price

Select period
Select period
Vaxart
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

Return on Investment VXRT

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
-6.71%
3 months
-11.82%
1 year
25.97%
2 years
-46.12%
5 years
-93.84%
10 years
-97.33%
Fundamental indicators

Fundamentals VXRT

Check the fundamentals of Vaxart shares.

Valuation

P/E
3.04
Sector -3.52
Industry -3.52
P/BV
1.42
Sector 2.04
Industry 2.04
P/Revenue (PSR)
0.48
Sector 2.02
Industry 2.02
EV/EBITDA
-4.38
Sector -223.26
Industry -223.26
EV/EBIT
-4.13
Sector -47.66
Industry -47.66
P/EBITDA
2.49
Sector -21.38
Industry -21.38
P/EBIT
2.85
Sector -28.46
Industry -28.46
P/Total Assets
0.71
Sector 1.19
Industry 1.19
P/Net Current Assets
3.46
Sector -10.28
Industry -10.28
P/Working Capital
2.69
Sector -169.36
Industry -169.36
EPS
0.16
Sector -1.81
Industry -1.81
BVPS
0.34
Sector 2.06
Industry 2.06

Efficiency

Gross Margin
100.00%
Sector 41.30%
Industry 41.30%
EBITDA Margin
-44.85%
Sector -17,117.21%
Industry -17,117.21%
EBIT Margin
-47.57%
Sector -4,185,659.35%
Industry -4,185,659.35%
Operating Margin
16.30%
Sector -35.21%
Industry -35.21%
Net Profit Margins
15.88%
Sector -35.91%
Industry -35.91%
Asset Turnover
0.16
Sector 0.02
Industry 0.02

Profitability

ROE
46.86%
Sector -56.04%
Industry -56.04%
ROA
23.37%
Sector -60.31%
Industry -60.31%
ROIC
-80.48%
Sector -2,355.96%
Industry -2,355.96%

Dividends

Dividend yield
0.00%
Sector -
Industry -
Payout
0.00%
Sector -
Industry -

Debt

Current Ratio
1.60
Sector 2.89
Industry 2.89
Net Debt / EBITDA
5.25
Sector -14,081,727.50
Industry -14,081,727.50
Net Debt / EBIT
4.95
Sector -8.06
Industry -8.06
Net Debt / Equity
-0.78
Sector -33,024.69
Industry -33,024.69
Gross Debt / Equity
0.00
Sector -0.85
Industry -0.85
Equity/Assets
0.50
Sector 0.46
Industry 0.46
Liabilities/Assets
0.50
Sector 0.41
Industry 0.41

Growth

5Y Revenue CAGR
207.09%
Sector -
Industry -
5Y Earnings CAGR
0.00%
Sector -
Industry -
Fundamental indicators history

Fundamentals VXRT

RETORNO DO INVESTIMENTO

FAIR VALUE OF Vaxart ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.49

Fair Value

$1.11

Upside

128.11%
ranking See Graham's ranking
Because it considers equity value in its calculation, this formula may not work well for technology companies.
This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.
Buy And Hold Investor Checklist

Vaxart Buy And Hold Investor Checklist


This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]
Price

COMPARING VXRT WITH OTHER STOCK

Price

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.
Price

VXRT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

ABOUT

Logo Vaxart

Vaxart Inc.

Average Investor10 user rating

4.0 (2 people)

United States

United States

57 years

Founded: 1969

1990

Time since IPO - 36 years

49

Employees

Market cap

$117.37 million

$117.37 million

Net worth

$82.37 million

$82,370,000.00

Assets

$165.19 million

$165,190,000.00

Total Shares Outstanding

242.00 million

242,000,000

Average Daily Trading Volume

$290.85 Thousand

$290,854.00

Sector

Health Care

Industry

Biotechnology

Shares

VXRT
receitas e lucros

VXRT revenue and profits

Price

PROFIT X PRICE VXRT

Financials

Financial Results VXRT

DRAG THE FRAME TO SEE MORE DATA
Financials

VXRT cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - VXRT

Pontos Relevantes

VXRT balance sheet

DRAG THE FRAME TO SEE MORE DATA
Discover more assets
Logo Biofrontera

BFRA - Biofrontera

$- -0,00% (12M)
P/E

0.00

DY

0.00%

ROE

-893.55%

P/BV

0.00
Logo McKesson

MCK - McKesson

$874.67 25,90% (12M)
P/E

19.68

DY

0.37%

ROE

-137.16%

P/BV

-26.99
Logo Cardinal Health

CAH - Cardinal Health

$224.45 51,94% (12M)
P/E

31.71

DY

0.88%

ROE

-63.29%

P/BV

-20.07
Logo Johnson & Johnson

JNJ - Johnson & Johnson

$269.33 56,33% (12M)
P/E

30.47

DY

1.98%

ROE

24.76%

P/BV

7.54
Logo AbbVie

ABBV - AbbVie

$263.93 22,42% (12M)
P/E

72.22

DY

2.65%

ROE

-106.44%

P/BV

-76.87
Logo Merck & Co.

MRK - Merck & Co.

$146.11 86,25% (12M)
P/E

112.32

DY

2.33%

ROE

7.55%

P/BV

8.48
Logo AstraZeneca

AZN - AstraZeneca

$166.35 9,17% (12M)
P/E

19.00

DY

2.03%

ROE

25.77%

P/BV

4.89
Logo Pfizer

PFE - Pfizer

$27.49 22,43% (12M)
P/E

35.93

DY

6.24%

ROE

5.11%

P/BV

1.84
Logo Biofrontera

BFRA - Biofrontera

$- -0,00% (12 M)
P/L

0.00

DY

0.00%

ROE

-893.55%

P/VP

0.00
Logo McKesson

MCK - McKesson

$874.67 25,90% (12 M)
P/L

19.68

DY

0.37%

ROE

-137.16%

P/VP

-26.99
Logo Cardinal Health

CAH - Cardinal Health

$224.45 51,94% (12 M)
P/L

31.71

DY

0.88%

ROE

-63.29%

P/VP

-20.07
Logo Johnson & Johnson

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)
P/L

30.47

DY

1.98%

ROE

24.76%

P/VP

7.54
Logo AbbVie

ABBV - AbbVie

$263.93 22,42% (12 M)
P/L

72.22

DY

2.65%

ROE

-106.44%

P/VP

-76.87
Logo Merck & Co.

MRK - Merck & Co.

$146.11 86,25% (12 M)
P/L

112.32

DY

2.33%

ROE

7.55%

P/VP

8.48
Logo AstraZeneca

AZN - AstraZeneca

$166.35 9,17% (12 M)
P/L

19.00

DY

2.03%

ROE

25.77%

P/VP

4.89
Logo Pfizer

PFE - Pfizer

$27.49 22,43% (12 M)
P/L

35.93

DY

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of Vaxart (VXRT) today?

A cotação de Vaxart (VXRT) hoje está em US$ 0.49, com uma variação de 25.97% em relação ao último ano. A cotação de Vaxart (VXRT) iniciou o ano negociando na casa dos US$ 0.35 e hoje está em US$ 0.49. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Vaxart (VXRT) e dados de ações do Ibovespa e mercados internacionais.

Quando Vaxart (VXRT) paga dividendos?

Vaxart (VXRT) não distribuiu dividendos no último ano.

Is Vaxart (VXRT) a good investment?

Atualmente, Vaxart (VXRT) está cotada a US$ 0.49, com um P/L de 3.04, representando um desvio de 69% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 25.97 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 25.97%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Vaxart (VXRT) stock?

Investir em ações de Vaxart (VXRT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Vaxart (VXRT) yield today?

A rentabilidade de Vaxart (VXRT) foi de -6.71% no último mês, 25.97% no último ano e -93.84% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Vaxart (VXRT) hoje, o investimento total seria de US$ 48.50, com base na cotação atual de US$ 0.49.

Based on historical performance, the investment would have grown to approximately:

  • Em 1 ano: US$ 61.10
  • Em 5 anos: US$ 2.99
  • Em 10 anos: US$ 1.29

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.